NextCure (NXTC) Earnings Date & Reports

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NXTC is expected to report earnings to fall 9.52% to -37 cents per share on May 01

Q1'25

Est.

$-0.38

Q4'24

Missed

by $0.08

Q3'24

Missed

by $0.06

Q2'24

Missed

by $0.17

Q1'24

Missed

by $0.17

The last earnings report on March 06 showed earnings per share of -41 cents, missing the estimate of -34 cents. With 88.12K shares outstanding, the current market capitalization sits at 11.20M.

View a ticker or compare two or three

Compare

NXTC